European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Hospitals by Country

The European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by hospitals as a percentage of GDP in 2023 was led by Malta (0.76%) with a remarkable 14.87% year-on-year increase. France and Switzerland experienced moderate increases of 5.06% and 5.92% respectively, while Italy recorded a slight rise of 2.9%. Conversely, Cyprus and the Netherlands faced reductions in their expenditures. Notably, Lithuania had a significant 24.57% increase. Over the last five years, the compound annual growth rate highlighted spending fluctuations, indicating varying prioritization of healthcare resources among these countries.

Future trends to watch:

• Increasing healthcare spending in Malta and Ireland, driven by demographic and policy changes.
• Potential expenditure cuts in the Netherlands and the Czech Republic reflecting budgetary constraints.
• Broader impacts of European Union healthcare policies and innovations on expenditure patterns.
• Technology-driven healthcare solutions potentially reshaping spending on pharmaceuticals and non-durable goods.